The professor behind the study said the ingredient 'could be used in clinical practice' ...
Morning Overview on MSN
Major review finds new Alzheimer’s drugs offer no meaningful patient benefit
For the millions of families watching a loved one slip away to Alzheimer’s disease, the arrival of drugs that promised to ...
Luxturna was the first FDA-approved gene therapy for a disease caused by mutations in a specific gene. It helped establish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results